Amanote Research
Register
Sign In
In Vitro Activity of the New Fluoroquinolone CP-99,219.
Antimicrobial Agents and Chemotherapy
- United States
doi 10.1128/aac.38.11.2615
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Pharmacology
Date
November 1, 1994
Authors
H C Neu
N X Chin
Publisher
American Society for Microbiology
Related search
In Vitro Activity of BAY 12-8039, a New Fluoroquinolone.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Susceptibilities of Mycoplasma Pneumoniae, Mycoplasma Hominis, and Ureaplasma Urealyticum to a New Quinolone, Trovafloxacin (CP-99,219).
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Dose-Ranging Study of CP-99,219 (Trovafloxacin) for Treatment of Uncomplicated Gonorrhea.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Activity of CP 99,219 Compared With Those of Ciprofloxacin, Grepafloxacin, Metronidazole, Cefoxitin, Piperacillin, and Piperacillin-Tazobactam Against 489 Anaerobes.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro and in Vivo Antibacterial Activities of T-3262, a New Fluoroquinolone.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative in Vitro Activities of Trovafloxacin (CP-99,219) Against 445 Gram-Positive Isolates From Patients With Endocarditis and Those With Other Bloodstream Infections.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activities of Y-688, a New 7-Substituted Fluoroquinolone, Against Anaerobic Bacteria
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Fluoroquinolone Resistance in Staphylococcal Endophthalmitis Isolates
Archives of Ophthalmology
